DelveInsight's 'Dry Age-Related Macular Degeneration Pipeline Insight 2025' report provides comprehensive global coverage of ...

Brain-computer interfaces translate neural signals into actions, revolutionizing healthcare and enhancing communication for individuals with disabilities.

Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced the company will encore data from the BEACON Phase 1/2 ...

RBC Capital analyst Brian Abrahams maintained a Hold rating on SAGE Therapeutics (SAGE – Research Report) on January 21 and set a price target ...

Cellipont Bioservices, a leading cell therapy Contract Development and Manufacturing Organization (CDMO), and Secretome Therapeutics, a biotechnology company advancing therapies derived from neonatal ...

Orphan drugs offer critical treatment options for rare diseases, improving quality of life for underserved patients and ...

Icelandic drug discovery and development company Arctic Therapeutics (ATx) today announced the successful closing of a ?26.5 million oversubscribed Series A financing from a broad syndicate ...

Icelandic drug discovery and development company Arctic Therapeutics (ATx) today announced the successful closing of a €26.5 ...

SAN DIEGO, CA and SOUTH SAN FRANCISCO, CA / / January 21, 2025 / Dermata Therapeutics, Inc. (NASDAQ:DRMA)(NASDAQ:DRMAW) ('Dermata') and Revance Therapeutics, Inc. (Nasdaq: RVNC) ('Revance' together ...

BioLineRx Ltd. , a clinical-stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, today issued the following letter to shareholders. To my fellow shareholders ...